STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
IRWD IRONWOOD PHARMACEUTICALS INCORPORATED StockScouter® Report
3
StockScouter® Score
IRONWOOD PHARMACEUTICALS INCORPORATED, a small cap value company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
Concerns
- One or more analysts has significantly decreased quarterly earnings estimates for IRWD. Negative
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
- The multi-period measure of relative price change and consistency is well below average. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, value stocks will be in favor, and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
C
D
D
F